PMC:7164855 / 4823-5264 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T31","span":{"begin":60,"end":61},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Declaration of Competing Interest\nToshiaki Kikuchi received a research grant from 10.13039/100004325AstraZeneca. Toshiaki Kikuchi received lecture fees from 10.13039/100010793Pfizer Japan, Daiichi Sankyo, 10.13039/100010795Chugai Pharmaceutical, Nippon 10.13039/100001003Boehringer Ingelheim, and AstraZeneca. Toshiaki Kikuchi received subsidies from Chugai Pharmaceutical, 10.13039/100014422Eli Lilly Japan, and Nippon Boehringer Ingelheim."}

{"project":"LitCovid-sentences","denotations":[{"id":"T31","span":{"begin":0,"end":33},"obj":"Sentence"},{"id":"T32","span":{"begin":34,"end":112},"obj":"Sentence"},{"id":"T33","span":{"begin":113,"end":309},"obj":"Sentence"},{"id":"T34","span":{"begin":310,"end":441},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Declaration of Competing Interest\nToshiaki Kikuchi received a research grant from 10.13039/100004325AstraZeneca. Toshiaki Kikuchi received lecture fees from 10.13039/100010793Pfizer Japan, Daiichi Sankyo, 10.13039/100010795Chugai Pharmaceutical, Nippon 10.13039/100001003Boehringer Ingelheim, and AstraZeneca. Toshiaki Kikuchi received subsidies from Chugai Pharmaceutical, 10.13039/100014422Eli Lilly Japan, and Nippon Boehringer Ingelheim."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T79","span":{"begin":230,"end":244},"obj":"CHEBI:52217;CHEBI:52217"},{"id":"T80","span":{"begin":358,"end":372},"obj":"CHEBI:52217;CHEBI:52217"},{"id":"T88560","span":{"begin":230,"end":244},"obj":"CHEBI:52217;CHEBI:52217"},{"id":"T84361","span":{"begin":358,"end":372},"obj":"CHEBI:52217;CHEBI:52217"}],"text":"Declaration of Competing Interest\nToshiaki Kikuchi received a research grant from 10.13039/100004325AstraZeneca. Toshiaki Kikuchi received lecture fees from 10.13039/100010793Pfizer Japan, Daiichi Sankyo, 10.13039/100010795Chugai Pharmaceutical, Nippon 10.13039/100001003Boehringer Ingelheim, and AstraZeneca. Toshiaki Kikuchi received subsidies from Chugai Pharmaceutical, 10.13039/100014422Eli Lilly Japan, and Nippon Boehringer Ingelheim."}